S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

Enlivex Therapeutics (ENLV) News Today

$1.32
-0.08 (-5.71%)
(As of 04/19/2024 ET)
SourceHeadline
msn.com logoYet Another Biotech Stock Has Found Success During Tuesday's Session
msn.com - April 18 at 2:11 AM
msn.com logoEnlivex Therapeutics (ENLV) Price Target Decreased by 41.67% to 7.14
msn.com - April 17 at 10:11 AM
finance.yahoo.com logoEnlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
finance.yahoo.com - April 16 at 8:19 AM
globenewswire.com logoEnlivex Announces Authorization from the Danish Regulatory Agency for the Company's Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
globenewswire.com - April 16 at 7:50 AM
MarketBeat logoEnlivex Therapeutics Ltd. Expected to Post FY2025 Earnings of ($0.55) Per Share (NASDAQ:ENLV)
americanbankingnews.com - April 15 at 1:50 AM
MarketBeat logoEnlivex Therapeutics (NASDAQ:ENLV) Price Target Lowered to $7.00 at HC Wainwright
americanbankingnews.com - April 14 at 3:36 AM
stockhouse.com logoEnlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra(TM) In Patients With Sepsis
stockhouse.com - April 13 at 2:33 PM
marketbeat.com logoEnlivex Therapeutics (NASDAQ:ENLV) Price Target Cut to $7.00 by Analysts at HC Wainwright
marketbeat.com - April 12 at 8:14 AM
finance.yahoo.com logoEnlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis
finance.yahoo.com - April 11 at 7:35 PM
globenewswire.com logoEnlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis
globenewswire.com - April 11 at 2:58 PM
msn.com logoNasdaq Gains Over 50 Points; US Producer Prices Increase In March
msn.com - April 11 at 2:35 PM
msn.com logoDow Dips 100 Points; CarMax Earnings Miss Views
msn.com - April 11 at 2:35 PM
msn.com logoEnlivex stock plunges 50% on mixed results from sepsis study
msn.com - April 11 at 2:35 PM
globenewswire.com logoEnlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
globenewswire.com - April 11 at 8:05 AM
msn.com logoENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023
msn.com - April 5 at 11:12 AM
marketbeat.com logoEnlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Up 15.4% in March
marketbeat.com - April 2 at 9:24 PM
marketbeat.com logoEnlivex Therapeutics (ENLV) Set to Announce Quarterly Earnings on Tuesday
marketbeat.com - April 1 at 11:36 AM
finanznachrichten.de logoEnlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV
finanznachrichten.de - March 22 at 7:35 PM
marketbeat.com logoShort Interest in Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Expands By 51.2%
marketbeat.com - March 16 at 5:36 PM
finance.yahoo.com logoENLV Apr 2024 7.500 call
finance.yahoo.com - March 16 at 2:24 AM
edition.cnn.com logoEnlivex Therapeutics Ltd.
edition.cnn.com - March 9 at 7:06 PM
marketbeat.com logoEnlivex Therapeutics (NASDAQ:ENLV) Trading Up 6.5%
marketbeat.com - March 5 at 2:21 AM
finance.yahoo.com logoEnlivex Receives Regulatory Authorization From Israel’s Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
finance.yahoo.com - February 26 at 9:29 AM
benzinga.com logoEnlivex Therapeutics Stock (NASDAQ:ENLV), Short Interest Report
benzinga.com - February 22 at 1:01 PM
finance.yahoo.com logoENLV May 2024 5.000 put
finance.yahoo.com - February 22 at 8:00 AM
finance.yahoo.com logoEnlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
finance.yahoo.com - February 7 at 10:08 AM
finance.yahoo.com logoEnlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
finance.yahoo.com - January 17 at 8:49 AM
finance.yahoo.com logoEnlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
finance.yahoo.com - December 20 at 8:34 AM
morningstar.com logoEnlivex Therapeutics Ltd ENLV
morningstar.com - December 16 at 6:19 PM
finance.yahoo.com logoIs Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - December 12 at 8:46 AM
finance.yahoo.com logoMediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
finance.yahoo.com - November 21 at 7:37 AM
finance.yahoo.com logoEnlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
finance.yahoo.com - September 11 at 8:49 AM
finance.yahoo.com logoEnlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - September 7 at 6:56 PM
finance.yahoo.com logoEnlivex Announces Peer-Reviewed Publication in Frontiers in Immunology of Clinical Data Details Resolution of Acute Respiratory Distress Syndrome (ARDS) from two Phase I/II Trials Evaluating Allocetra in Patients with COVID-19
finance.yahoo.com - August 2 at 6:54 PM
finance.yahoo.com logoEnlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra™ In Patients With Sepsis
finance.yahoo.com - July 31 at 9:30 AM
finance.yahoo.com logoEnlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
finance.yahoo.com - June 26 at 9:25 AM
benzinga.com logoThis Biotech Is Bringing Balance To The Body – How Homeostasis Is Critical To Fighting Everything From Sepsis To Cancer
benzinga.com - June 16 at 2:03 PM
finance.yahoo.com logoEnlivex to Present at the 2023 Jefferies Healthcare Conference
finance.yahoo.com - June 6 at 9:44 AM
finance.yahoo.com logoEnlivex Selected for an Elevator Pitch Presentation and two additional Poster Presentations at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy
finance.yahoo.com - May 31 at 10:09 AM
finance.yahoo.com logoEnlivex Announces Issuance of European Patent Covering the Use of Allocetra™ to Prevent Cytokine Release Syndrome (CRS) Resulting from CAR T-Cell Therapy
finance.yahoo.com - May 8 at 8:21 AM
marketwatch.com logoEnlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra(TM) in Patients Receiving CAR T-Cell Therapy
marketwatch.com - April 20 at 8:32 AM
finance.yahoo.com logoEnlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
finance.yahoo.com - April 19 at 10:19 AM
finance.yahoo.com logoEnlivex Appoints Andrew Singer to its Board of Directors
finance.yahoo.com - April 17 at 12:55 PM
finance.yahoo.com logoAnalysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials
finance.yahoo.com - April 14 at 1:18 PM
finanznachrichten.de logoEnlivex Therapeutics Ltd.: Enlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors
finanznachrichten.de - April 12 at 3:23 PM
benzinga.com logoEnlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors
benzinga.com - April 11 at 12:49 PM
msn.com logoHC Wainwright & Co. Reiterates Enlivex Therapeutics (ENLV) Buy Recommendation
msn.com - April 5 at 7:25 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Their Buy Rating for Enlivex (ENLV)
markets.businessinsider.com - April 5 at 9:23 AM
finanznachrichten.de logoEnlivex Therapeutics Ltd: Enlivex Announces Tislelizumab Clinical Collaboration, Full Year 2022 Financial Results, and Provides Business Updates
finanznachrichten.de - April 4 at 9:33 AM
finance.yahoo.com logoEnlivex Announces Tislelizumab Clinical Collaboration, Full Year 2022 Financial Results, and Provides Business Updates
finance.yahoo.com - April 4 at 9:33 AM
Get Enlivex Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENLV and its competitors with MarketBeat's FREE daily newsletter.

“More countries ditch the US dollar” (Ad)

Since March 2018, China started purchasing oil in gold-backed yuan. By December 2022, Foreign Minister Wang Yi stated that Chinese-Arab relations experienced a "historic improvement." after arab nations ditched the dollar to trade with China. On June 6, 2023 China told its banks to slash interest rates on US dollars.

Get all the details here.

ENLV Media Mentions By Week

ENLV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENLV
News Sentiment

0.40

0.49

Average
Medical
News Sentiment

ENLV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENLV Articles
This Week

8

0

ENLV Articles
Average Week

Get Enlivex Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENLV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ENLV) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners